lx1001
·Code: LX1001
lx1001: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | Phase 1 |
Clinical Trials (1)
Long-Term Follow-Up to Evaluate the Safety of LX1001 in Participants With APOE4 Homozygote Alzheimer's Disease
Frequently asked questions
Who is developing lx1001?
lx1001 is being developed by Lexeo Therapeutics, Inc..
How many clinical trials involve lx1001?
BioSniper tracks 1 clinical trial involving lx1001.
Get deeper analysis on lx1001
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis